Test Laboratories Sample Clauses

Test Laboratories. The Test Laboratories agree to run three lab-financed Sequence VID tests on each Matrix test stand to ensure proper test calibration. The Matrix requires two stands at each Test Laboratory. These test stands will be considered calibrated upon the successful completion of the Sequence VID Test Matrix and in compliance with calibration criteria as determined by the Sequence VI Surveillance Panel. The calibration period will begin concurrently with the effective date of ACC registration of the VID. To maintain confidentiality of pricing information, the full and final prices paid to a Matrix Lab are shown only on that Matrix Lab’s copy of this MOA and the master copy kept by API.  Intertek Automotive Research will provide to ASTM, at no charge, the pertinent data and results of 6 tests for the Sequence VID matrix. Intertek also commits to conduct 16 tests for the Sequence VID matrix at the fixed full and final price of .  Southwest Research Institute will provide to ASTM, at no charge, the pertinent data and results of 6 tests for the Sequence VID matrix. Southwest Research Institute also commits to conduct 16 tests for the Sequence VID matrix at the fixed full and final price of . All tests submitted by the Test Laboratories must be operationally valid. Operational validity of engine tests will be determined by the testing laboratory using guidance from the ASTM TMC and input from the Project Supervisor using guidelines established by the ASTM Sequence VI Surveillance Panel prior to the start of the matrix. Matrix tests that are determined to be operationally invalid will be re-run at the test laboratory’s expense. The Test Laboratories are not responsible for performing any testing beyond what is stated above. TEST SCHEDULE Sequence VID testing will begin when the test has been formally affirmed "ready for Matrix testing" by the PCEOCP and all other conditions set forth in Scope have been met. Testing shall be conducted in accordance with the approved Test Matrix (see Attachment). The targeted completion date for the Sequence VID Test Matrix is three (3) months after its commencement date. The stands included in the Test Matrix should be used exclusively for matrix testing until the assigned tests in those stands have been completed. The commencement date is the date that the first Matrix test begins. Extension of the timing past this targeted completion date must be approved by the ILSAC/Oil Committee.
AutoNDA by SimpleDocs
Test Laboratories. Each Party shall notify the other of the test laboratories designated to carry out the tests pertaining to the procedures referred to in Article 10 of Directive 98/13/EC. The criteria fixed by the relevant harmonised standards for the designation of such laboratories shall be applied.
Test Laboratories. The Test Laboratories agree to provide the following resources to ASTM for use in the PC-10 Test Matrix. Caterpillar C13 Cummins ISB Xxxx T-12 Lab Lab Financed Runs ACC/API/EMA Financed Runs Lab Financed Runs ACC/API/EMA Financed Runs Lab Financed Runs ACC/API/EMA Financed Runs PerkinElmer SwRI To maintain confidentiality of pricing information, the full and final prices paid to a lab are shown only on that lab’s copy and the master copy kept by API. • PerkinElmer will provide to ASTM, at no charge, the pertinent data and results of ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx T-12 tests for the PC-10 matrix. PerkinElmer also commits to conduct ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx X-12 tests for the PC-10 matrix at the full and final price of . • Southwest Research Institute will provide to ASTM, at no charge, the pertinent data and results of ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx T-12 tests for the PC-10 matrix. Southwest Research also commits to conduct ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) Xxxx X-12 tests for the PC-10 matrix at the full and final price of . All tests submitted by the Test Laboratories must be operationally valid. Operational validity of engine tests will be determined by the testing laboratory using guidance from the ASTM Test Monitoring Center (hereinafter the "ASTM TMC") and input from the Project Manager using guidelines established by appropriate ASTM Surveillance Panels prior to the start of each matrix. Matrix tests that are determined to be operationally invalid will be re-run at the cost of the test laboratory. The Test Laboratories are not responsible for performing any testing beyond what is stated above. TEST MANAGEMENT ASTM and the appropriate ASTM committees agree to act as the fund and test administrators for the PC-10 matrix. The responsibilities of ASTM and the ASTM committees are as follows: • ASTM will act as the fund-dispersing agency for the PC-10 matrix. API, ACC, and EMA will be invoiced as described above in Agreement Concerning Funding and Resources, section (a), second paragraph, according to the contribution level of each association. ASTM will disburse funds to the Test Laboratories on a per test basis. • ASTM HDEOCP will be responsible for the management of the PC-10 matrix testing. The PC-10 New Category Development Team (hereinafter the “PC-10 NCDT”) and API/EMA Diesel Engine Oil Advisory Panel (hereinafter the “DEOAP”) will provide oversight...

Related to Test Laboratories

  • Treatment Program Testing The Employer may request or require an employee to undergo drug and alcohol testing if the employee has been referred by the employer for chemical dependency treatment or evaluation or is participating in a chemical dependency treatment program under an employee benefit plan, in which case the employee may be requested or required to undergo drug or alcohol testing without prior notice during the evaluation or treatment period and for a period of up to two years following completion of any prescribed chemical dependency treatment program.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Annual Production Program document describing the forecasts for Production and handling of Oil, Gas, water, special fluids, and waste arising from the Production process of each Development Area or Field.

  • Laboratory Services Covered Services include prescribed diagnostic clinical and anatomic pathological laboratory services and materials when authorized by a Member's PCP and HPN’s Managed Care Program.

  • Technology Research Analyst Job# 1810 General Characteristics Maintains a strong understanding of the enterprise’s IT systems and architectures. Assists in the analysis of the requirements for the enterprise and applying emerging technologies to support long-term business objectives. Responsible for researching, collecting, and disseminating information on emerging technologies and key learnings throughout the enterprise. Researches and recommends changes to foundation architecture. Supports research projects to identify and evaluate emerging technologies. Interfaces with users and staff to evaluate possible implementation of the new technology in the enterprise, consistent with the goal of improving existing systems and technologies and in meeting the needs of the business. Analyzes and researches process of deployment and assists in this process.

  • Specialty Prescription Drugs (+ Prorated copayments for a shorter supply period may apply for network pharmacy only. See Prescription Drug section for details. When purchased at a Specialty Pharmacy (+): For maintenance and non-maintenance prescription drugs, a copayment applies for each 30-day period (or portion thereof) within the prescribeddosing period. Tier 5: $125 Not Covered When purchased at a Retail Pharmacy (+): For maintenance and non-maintenance prescription drugs, a copayment applies for each 30-day period (or portion thereof) within the prescribeddosing period. Specialty Prescription Drugs purchasedat a retail pharmacy will require a significantly higher out of pocket expense than if purchased from a Specialty Pharmacy. Our reimbursement is based on the pharmacy allowance. Tier 5: 50% Not Covered When purchased at a Mail Order Pharmacy: Not Covered Not Covered Covered Benefits Network Pharmacy Non-network Pharmacy (+) Preauthorization is required for thisservice. Please see Preauthorization in Section 3 for more information. You Pay You Pay Infertility Prescription Drugs - Three(3) in-vitro cycles will be covered per plan year with a total of eight (8) in-vitro cycles covered in a member’s lifetime. When purchased at a Specialty, Mail Order, or Retail Pharmacy Tier 1: 20% Not Covered Tier 2: 20% Not Covered Tier 3: 20% Not Covered Tier 4: 20% Not Covered When purchased at a Specialty Pharmacy (+) Tier 5: 20% Not Covered When purchased at a Retail Pharmacy (+): Specialty Prescription Drugs purchased at a retail pharmacy will require a significantly higher out of pocket expense than if purchased from a specialty pharmacy. Tier 5: 20% Not Covered Contraceptive Methods- Preventive Coverage includes barrier method (diaphragmor cervical cap), hormonal method (birth control pill), and emergency contraception. For non-preventive contraceptive prescription drugs and devices, the amount you pay will depend on the tier placement of the contraceptive prescription drug or device. See above for details. When purchased at a Retail Pharmacy: Up to a 365-day supply of contraceptive prescription drugs is available at all network retail pharmacies. For more information about this option, visit our website. Tier 1: $0 Not Covered When purchased at a Mail Order Pharmacy: Up to a 90-day supply. Tier 1: $0 Not Covered

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Health Screening The Contractor shall conduct a Health Needs Screen (HNS) for new members that enroll in the Contractor’s plan. The HNS will be used to identify the member’s physical and/or behavioral health care needs, special health care needs, as well as the need for disease management, care management and/or case management services set forth in Section 3.8. The HNS may be conducted in person, by phone, online or by mail. The Contractor shall use the standard health screening tool developed by OMPP, i.e., the Health Needs Screening Tool, but is permitted to supplement the OMPP Health Needs Screening Tool with additional questions developed by the Contractor. Any additions to the OMPP Health Needs Screening Tool shall be approved by OMPP. The HNS shall be conducted within ninety (90) calendar days of the Contractor’s receipt of a new member’s fully eligible file from the State. The Contractor is encouraged to conduct the HNS at the same time it assists the member in making a PMP selection. The Contractor shall also be required to conduct a subsequent health screening or comprehensive health assessment if a member’s health care status is determined to have changed since the original screening, such as evidence of overutilization of health care services as identified through such methods as claims review. Non-clinical staff may conduct the HNS. The results of the HNS shall be transferred to OMPP in the form and manner set forth by OMPP. As part of this contract, the Contractor shall not be required to conduct HNS for members enrolled in the Contractor’s plan prior to January 1, 2017 unless a change in the member’s health care status indicates the need to conduct a health screening. For purposes of the HNS requirement, new members are defined as members that have not been enrolled in the Contractor’s plan in the previous twelve (12) months. Data from the HNS or NOP form, current medications and self-reported medical conditions will be used to develop stratification levels for members in Hoosier Healthwise. The Contractor may use its own proprietary stratification methodology to determine which members should be referred to specific care coordination services ranging from disease management to complex case management. OMPP shall apply its own stratification methodology which may, in future years, be used to link stratification level to the per member per month capitation rate. The initial HNS shall be followed by a detailed Comprehensive Health Assessment Tool (CHAT) by a health care professional when a member is identified through the HNS as having a special health care need, as set forth in Section 4.2.4, or when there is a need to follow up on problem areas found in the initial HNS. The detailed CHAT may include, but is not limited to, discussion with the member, a review of the member’s claims history and/or contact with the member’s family or health care providers. These interactions shall be documented and shall be available for review by OMPP. The Contractor shall keep up-to-date records of all members found to have special health care needs based on the initial screening, including documentation of the follow-up detailed CHAT and contacts with the member, their family or health care providers.

Time is Money Join Law Insider Premium to draft better contracts faster.